Anti-IL-2 mAb activates Tregs to treat autoimmune diseases

In a paper published in Nature Medicine, scientists generated a human mAb against IL-2 that preferentially activates Tregs and could help treat autoimmune diseases.

Previous studies have shown that low doses of

Read the full 318 word article

User Sign In